Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Shouval

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|August 9, 2003
Late cytomegalovirus disease following liver transplantationOren Shibolet, Yaron Ilan, Yosef Kalish, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 26, 2005
Air transportation of patients with end-stage liver disease to distant liver transplantation centersOren Shibolet, Mina Rowe, Rifaat Safadi, et al.
World Journal of Gastroenterology|May 16, 2013
Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinomaMatan J Cohen, Allan I Bloom, Orly Barak, et al.
Journal of Hepatology|September 16, 2003
Liver micro-organs transcribe albumin and clotting factors and increase survival of 92% hepatectomized ratsEtty Grad-Itach, Alicia Graciela Fuchs, Haya Lev, et al.
Transplantation|March 22, 2002
Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistanceRivka Shapira, Nilli Daudi, Athallia Klein, et al.
Hepatology, Medicine and Policy|October 6, 2018
Innovative sources for funding of viral hepatitis prevention and treatment in low- and middle-income countries: a roundtable meeting reportDavid FitzSimons, Greet Hendrickx, Johannes Hallauer, et al.
Vaccine|July 1, 2014
Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccineAdalbert Krawczyk, Charlotte Ludwig, Christoph Jochum, et al.
Vaccine|April 22, 2008
Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccinationMeir Mizrahi, Gadi Lalazar, Ami Ben Ya'acov, et al.
The Pediatric Infectious Disease Journal|March 14, 2003
Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferonCorina Hartman, Drora Berkowitz, Daniel Shouval, et al.
The American Journal of Gastroenterology|January 16, 2003
Genotypic and phenotypic resistance: longitudinal and sequential analysis of hepatitis B virus polymerase mutations in patients with lamivudine resistance after liver transplantationZiv Ben-Ari, Nili Daudi, Athalia Klein, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Transplant International : Official Journal of the European Society for Organ Transplantation|August 9, 2003
Late cytomegalovirus disease following liver transplantationOren Shibolet, Yaron Ilan, Yosef Kalish, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 26, 2005
Air transportation of patients with end-stage liver disease to distant liver transplantation centersOren Shibolet, Mina Rowe, Rifaat Safadi, et al.
World Journal of Gastroenterology|May 16, 2013
Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinomaMatan J Cohen, Allan I Bloom, Orly Barak, et al.
Journal of Hepatology|September 16, 2003
Liver micro-organs transcribe albumin and clotting factors and increase survival of 92% hepatectomized ratsEtty Grad-Itach, Alicia Graciela Fuchs, Haya Lev, et al.
Transplantation|March 22, 2002
Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistanceRivka Shapira, Nilli Daudi, Athallia Klein, et al.
Hepatology, Medicine and Policy|October 6, 2018
Innovative sources for funding of viral hepatitis prevention and treatment in low- and middle-income countries: a roundtable meeting reportDavid FitzSimons, Greet Hendrickx, Johannes Hallauer, et al.
Vaccine|July 1, 2014
Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccineAdalbert Krawczyk, Charlotte Ludwig, Christoph Jochum, et al.
Vaccine|April 22, 2008
Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccinationMeir Mizrahi, Gadi Lalazar, Ami Ben Ya'acov, et al.
The Pediatric Infectious Disease Journal|March 14, 2003
Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferonCorina Hartman, Drora Berkowitz, Daniel Shouval, et al.
The American Journal of Gastroenterology|January 16, 2003
Genotypic and phenotypic resistance: longitudinal and sequential analysis of hepatitis B virus polymerase mutations in patients with lamivudine resistance after liver transplantationZiv Ben-Ari, Nili Daudi, Athalia Klein, et al.
Pageof 10